Thermo Fisher Scientific Inc., the world leader in serving science, today announced the global launch of the Gibcoâ„¢ CTSâ„¢ ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the global launch of the Gibco (TM) CTS (TM) Compleo (TM) Fill and Finish System, an automated, functionally closed ...
Enein, MD, PhD, has found himself in a win-win situation: winning not one but two awards from the American Society of Gene + ...
A team of researchers at the Georgia Institute of Technology and Emory University has developed a deep-ultraviolet (UV) ...
For his work towards developing a novel cancer immunotherapy that turns tumors into their own vaccines, Fábio Rosa has ...
This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.
2h
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
Detailed price information for Nanoviricides Inc (NNVC-A) from The Globe and Mail including charting and trades.
RMAT granted based on promising initial clinical data, including previously disclosed recommended dose for expansion data of 92% ORR, 75% ≥CR ...
Officials at Caring Cross emphasize that the organization is dedicated to ensuring the global affordability of advanced therapies.
In a demonstration that could help pave the way for gene therapies with fewer side effects, several human cell types have ...
Cells are not isolated units; they continuously exchange proteins, genetic material, and even entire organelles with their ...
In a surprising medical revelation this year, researchers have confirmed what many women over 40 suspected for years: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results